Leigh MacMillan Archive — Page 2 of 82

March 12, 2026

Ion channel scientist David Clapham to deliver Discovery Lecture April 2

Over the course of his 50-year career, Clapham made fundamental contributions to the discovery and characterization of ion channels — proteins that allow charged particles (ions) to move across cell membranes.

By Leigh MacMillan
March 11, 2026

Updated terminology guide explains Vanderbilt Health’s facility names and acronyms

It’s important for any organization’s long-term success for everyone to be able to speak the same language, whether we are speaking with each other or communicating with the public. This document provides a guide for accurately doing so for internal uses.

Mariana Byndloss, DVM, PhD
March 10, 2026

Mariana Byndloss named NAS Frontiers of Science Fellow

The National Academy of Sciences’ program identifies future leaders of science and brings them together to develop their leadership potential.

By Leigh MacMillan
March 3, 2026

Vanderbilt Health and Bertis establish collaboration for cancer drug discovery

The collaboration will integrate Vanderbilt Health’s Molecular AI Initiative capabilities with Bertis’ deep proteomics and AI-enabled technologies to identify novel therapeutic targets and predictive biomarkers.

February 27, 2026

Demographic and histologic factors influence risk of colon polyp recurrence

Vanderbilt Health study supports shift toward dynamic surveillance that extends monitoring for patients with specific demographic and histologic risk profiles.

By Leigh MacMillan
February 25, 2026

Patients with atrial fibrillation face higher bleeding risks when treated with 2 common medications

While diltiazem remains an effective option for heart rate control in selected patients, bleeding risk posed by anticoagulants should be considered.

By Jake Lowary